Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
Mattias Mandorfer, Elmar Aigner, Manfred Cejna, et al.
Wiener klinische Wochenschrift (2023) Vol. 135, Iss. S3, pp. 493-523
Open Access | Times Cited: 22

Showing 22 citing articles:

Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis
Ahmed Ghallab, Daniela González, Ellen Strängberg, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 268-281
Open Access | Times Cited: 24
Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient
Mathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 744-752
Open Access | Times Cited: 13
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
Georg Semmler, Sonia Alonso López, Mònica Pons, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 1, pp. 76-83
Open Access | Times Cited: 12
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study
Mathias Jachs, Aitor Odriozola, Fanny Turón, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 12, pp. 1111-1120
Closed Access | Times Cited: 10
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis
Benedikt Hofer, Lukas Burghart, Emina Halilbasic, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 8, pp. 962-972
Open Access | Times Cited: 7
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta
Mathias Jachs, Lisa Sandmann, Lukas Hartl, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 248-257
Open Access | Times Cited: 6
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure
Georg Semmler, Sonia Alonso López, Mònica Pons, et al.
Hepatology (2024) Vol. 81, Iss. 2, pp. 609-624
Closed Access | Times Cited: 5
Insulin‐like growth factor‐1 in cirrhosis is linked to hepatic dysfunction and fibrogenesis and predicts liver‐related mortality
Lukas Hartl, Michael Schwarz, Benedikt Simbrunner, et al.
Alimentary Pharmacology & Therapeutics (2024)
Open Access | Times Cited: 5
Albumin-Bilirubin Score for Predicting the In-Hospital Mortality of Acute Upper Gastrointestinal Bleeding in Liver Cirrhosis
Ali Raza, Abdul Aziz Sahito, Riaz Hussain Khokhar, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 3, pp. 650-655
Closed Access
Correspondence on “Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD” - Authors' Reply
Benedikt Hofer, Wilhelmus J. Kwanten, Sven Francque
Journal of Hepatology (2025)
Closed Access
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertension
Georg Semmler, Lukas Hartl, Yuly P. Mendoza, et al.
Hepatology (2024) Vol. 80, Iss. 4, pp. 887-900
Closed Access | Times Cited: 3
Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosis
Benedikt Hofer, Ksenia Brusilovskaya, Benedikt Simbrunner, et al.
Hepatology (2023) Vol. 80, Iss. 5, pp. 1120-1133
Closed Access | Times Cited: 8
Does encephalopathy with early onset after TIPS impact on mortality?
Lukas Hartl, Andrea Kornfehl, Thomas Reiberger
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. e269-e270
Closed Access | Times Cited: 2
Anaemia is independently associated with mortality in patients with hepatocellular carcinoma
Tobias Meischl, Lorenz Balcar, Yeong-Ran Park, et al.
ESMO Open (2024) Vol. 9, Iss. 6, pp. 103593-103593
Open Access | Times Cited: 2
Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality
Lukas Hartl, Benedikt Simbrunner, Mathias Jachs, et al.
JHEP Reports (2023) Vol. 6, Iss. 1, pp. 100954-100954
Open Access | Times Cited: 5
High histamine levels are associated with acute‐on‐chronic liver failure and liver‐related death in patients with advanced chronic liver disease
Michael Schwarz, Benedikt Simbrunner, Mathias Jachs, et al.
Liver International (2024) Vol. 44, Iss. 11, pp. 2904-2914
Open Access | Times Cited: 1
Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques
David Hudson, Tamoor Afzaal, Hasan Bualbanat, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 1
Decreasing interleukin-6 levels after TIPS predict outcomes in decompensated cirrhosis
Andrea Kornfehl, Anja Tiede, Paul Hemetsberger, et al.
JHEP Reports (2024) Vol. 7, Iss. 4, pp. 101308-101308
Open Access | Times Cited: 1
Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: PRO
Justin M. Belcher
Kidney360 (2024) Vol. 5, Iss. 6, pp. 791-794
Open Access
Attitudes towards transjugular intrahepatic portosystemic shunt (TIPS) in Australia: a national survey of TIPS centres
Eric Kalo, Scott A. Read, Jacob George, et al.
BMJ Open Gastroenterology (2024) Vol. 11, Iss. 1, pp. e001308-e001308
Open Access
Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease: Authors' reply
Bernhard Scheiner, Nina Dominik, Mattias Mandorfer
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 4, pp. 542-543
Closed Access
Impact of catheter tip to hepatic vein ostium distance on the validity and prognostication of hepatic venous pressure gradient in cirrhosis
Hiang Keat Tan, Alfred Bingchao Tan, Kevin Kim‐Jun Teh, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Letter: NSBB for fatty liver disease—Still a long way to go. Authors' reply
Mathias Jachs, Rafael Paternostro, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 8, pp. 848-849
Open Access
Page 1

Scroll to top